NCT00852241

Rejuvenation of the Lower Eyelid Using a Combination of Two Hyaluronic Acid Fillers - a Pilot Study

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 18 (actual)
• Sponsor: The Cleveland Clinic · Academic / Other
• Sex: Female
• Age: 18 Years – 70 Years
• Healthy volunteers: Accepted

Summary

The primary objective of this study is to determine the efficacy and longevity of the use of Restylane® and Perlane® in combination for the rejuvenation of the infraorbital hollows and to measure patient satisfaction with this treatment

Detailed description

This study will examine the effectiveness of using Restylane® and Perlane® together in the treatment of the hollows in the under eye area. The combination of these treatments for use in the under eye area is considered investigational. An investigational therapy is a therapy that is not approved by the US Food and Drug Administration (FDA). Restylane® and Perlane® has been approved for treatment of moderate to severe facial wrinkles and folds, such as nasolabial folds by the FDA.

Conditions

• Infraorbital Hollows

Interventions

Type	Name	Description
DRUG	Restalyne	one syringe of Restylane® (1.0cc) will be used total for both tear trough areas.
DRUG	Perlane	One syringe of Perlane® (1.0cc) will be used total for both tear trough areas.

Timeline

• Start date: 2009-02-01
• Primary completion: 2009-09-01
• Completion: 2009-09-01
• First posted: 2009-02-26
• Last updated: 2018-03-12
• Results posted: 2018-03-12

Locations

1 site across 1 country: United States